WHO announces first international framework to reduce greenhouse gas emissions from pharmaceuticals
On July 29, the World Health Organization (WHO) announced its first international framework aimed at reducing greenhouse gas emissions generated during the manufacturing and distribution of pharmaceuticals. This initiative is driven by deep concern over the negative impact of climate change on the health of people worldwide, which is increasingly forcing individuals to migrate or flee their homes.
Currently, it is estimated that the healthcare sector accounts for approximately 5% of global greenhouse gas emissions. The pharmaceutical manufacturing process, in particular, consumes significant amounts of energy, making its environmental impact a critical issue. Through this new framework, the WHO aims to collaborate with national governments and relevant companies to build sustainable healthcare systems.
This initiative calls for the reduction of emissions across the entire pharmaceutical supply chain. Specifically, the adoption of more environmentally friendly manufacturing methods and the optimization of transportation efficiency are being considered. The WHO also emphasizes that decarbonization in medical settings is essential to reducing health risks caused by climate change.
Health authorities in countries including Japan will now proceed with emission reduction plans for their domestic pharmaceutical industries based on this framework. A new challenge is beginning to ensure the stable provision of necessary medical care while protecting the environment.